Combination therapy in the Col1a2(G610C) mouse model of Osteogenesis Imperfecta reveals an additive effect of enhancing LRP5 signaling and inhibiting TGFβ signaling on trabecular bone but not on cortical bone

Enhancing LRP5 signaling and inhibiting TGFβ signaling have each been reported to increase bone mass and improve bone strength in wild-type mice. Monotherapy targeting LRP5 signaling, or TGFβ signaling, also improved bone properties in mouse models of Osteogenesis Imperfecta (OI). We investigated wh...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone
Hlavní autoři: Kaupp, Shannon, Horan, Dan J., Lim, Kyung-Eun, Feldman, Henry A., Robling, Alexander G., Warman, Matthew L., Jacobsen, Christina M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7232829/
https://ncbi.nlm.nih.gov/pubmed/31648079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bone.2019.115084
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky